+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Contract Manufacturing - Global Market Trajectory & Analytics

  • ID: 347965
  • Report
  • July 2020
  • Region: Global
  • 295 Pages
  • Global Industry Analysts, Inc
1 of 2
Global Pharmaceutical Contract Manufacturing Market to Reach $141 Billion by 2027

Amid the COVID-19 crisis, the global market for Pharmaceutical Contract Manufacturing estimated at US$106.8 Billion in the year 2020, is projected to reach a revised size of US$141 Billion by 2027, growing at a CAGR of 4% over the analysis period 2020-2027. API, one of the segments analyzed in the report, is projected to record a 5.2% CAGR and reach US$51.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the FDF segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $31.5 Billion, While China is Forecast to Grow at 3.7% CAGR

The Pharmaceutical Contract Manufacturing market in the U.S. is estimated at US$31.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$24.9 Billion by the year 2027 trailing a CAGR of 3.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Advanced Drug Delivery Products Segment to Record 3.5% CAGR

In the global Advanced Drug Delivery Products segment, USA, Canada, Japan, China and Europe will drive the 3.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$15.4 Billion in the year 2020 will reach a projected size of US$19.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$16.1 Billion by the year 2027.We bring years of research experience to this 18th edition of our report. The 295-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Aenova Group
  • Ajinomoto Althea, Inc.
  • Albany Molecular Research Inc.
  • Alcami Corporation
  • Baxter International, Inc.
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions, Inc.
  • Cobra Biologics Holding AB
  • CordenPharma International
  • Dishman Group
  • Famar Health Care Services
  • Hospira, Inc.
  • Jubilant Life Sciences Limited
  • Kemwell Biopharma Pvt. Ltd.
  • Lonza Group Ltd.
  • LTS Lohmann Therapie-Systeme AG
  • NextPharma Technologies Holding Ltd.
  • Nipro Pharma Corporation
  • Recipharm AB
  • Vetter Pharma International GmbH

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 2

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Pharmaceutical Contract Manufacturing - A Prelude

Recent Market Activity

Current & Future Market Outlook

Sizing the Market

West Leads in PCM Services

Solid Dosage Remains Popular Among CMOs

Injectable-Dose Formulations to Spearhead Growth of the PCM Market

Opportunities Rife for PCM Growth

Key Market Drivers

Major Changes Imperative to Capitalize on Brighter Future Prospects

Global Competitor Market Shares

Pharmaceutical Contract Manufacturing Competitor Market Share Scenario Worldwide (in %): 2018 & 2029

Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

Aenova Group (Germany)

Ajinomoto Althea, Inc. (USA)

Albany Molecular Research Inc. (USA)

Alcami Corporation (USA)

Baxter International, Inc. (USA)

Boehringer Ingelheim GmbH (Germany)

Catalent Pharma Solutions, Inc. (USA)

Cobra Biologics Holding AB (Sweden)

CordenPharma International (Germany)

Dishman Group (India)

DPx Holdings B.V. (USA)

Fareva Group (Luxembourg)

Famar Health Care Services (Greece)

Hospira, Inc. (USA)

Jubilant Life Sciences Limited (India)

Kemwell Biopharma Pvt. Ltd. (India)

Lonza Group Ltd. (Switzerland)

LTS Lohmann Therapie-Systeme AG (Germany)

NextPharma Technologies Holding Ltd. (UK)

Nipro Pharma Corporation (Japan)

Recipharm AB (Sweden)

Vetter Pharma International GmbH (Germany)

3. MARKET TRENDS & DRIVERS

Changing Face of the CMO Industry

Relevance of CMOs Increases in the Modern Pharma Industry

Patent Expiries Augur Good Tidings for the PCM Market

PCMs Gear Up to Tap Booming Biologics Market

Biotechnology Start-Ups Spur Demand for Contract Manufacturing

Service Differentiation - The Key to Future Success in Solid Dosage Formulations Manufacturing

Strong Growth in Injectables Market to Resonate in Contract Manufacturing

Developed Markets Dominate Sterile Injectables Contract Manufacturing Market

PCM Market for Vaccines Yet to Take Off

PCM Industry Gravitates Eastward, and Subsequently Leads to Near-Shoring

Smaller Production Batches are Here to Stay; Compel Facility Efficiency Improvements

Upstream Movement Becomes a Compulsion for Many

Need to Focus on Better Customer Services Emerges

Rising Drug Complexity Presses for Specialized Expertise

Adoption of Cutting-Edge Technologies to Radicalize PCM Environment

RABS technology

Quality by Design

Track & Trace Techniques

Disposable Processing Techniques

Upstream & Downstream Processes

Process Analytical Technology

Near Infrared Spectroscopy

Perfusion Technology Takes Center-stage as Quality and Cost Concerns Rise

Downstream Processes Get a Lift as CMOs Seek Ways to Improve Capacity

Biopharma Contract Manufacturing Surges Ahead

Cost and Risk Containment Objectives Spur Outsourcing of Biopharma Production

Contract Manufacturing of ADCs Continues to Rise

Competition to Surge in Biological Contract Manufacturing Market

CMOs Gear Up for Capacity Expansions to Address Growing Demand from Biopharma

Ballooning Global Population Offers Increased Growth Opportunities

Aging Population Boosts Opportunities for PCM

Increasing Healthcare Expenditure to Spur Demand for Contract Manufacturing of Generics

Surge in Generic Drugs to Benefit Pharmaceutical Contract Manufacturers

Insourcing of Manufacturing Operations - An Emerging Threat to PCM

Vendor Switching- A Growing Concern for PCMs

New Challenges Threaten Prospects for CMOs

New Distribution Regulations Incites Changes in Operations

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Pharmaceutical Contract Manufacturing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Pharmaceutical Contract Manufacturing Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Pharmaceutical Contract Manufacturing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: API (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: API (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: API (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: FDF (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: FDF (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: FDF (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Advanced Drug Delivery Products (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Advanced Drug Delivery Products (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Advanced Drug Delivery Products (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: OTC Medicines & Nutritional Products (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: OTC Medicines & Nutritional Products (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: OTC Medicines & Nutritional Products (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Other Product Types (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 17: Other Product Types (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 18: Other Product Types (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Pharmaceutical (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
TABLE 20: Pharmaceutical (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
TABLE 21: Pharmaceutical (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
TABLE 22: Biopharmaceutical (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
TABLE 23: Biopharmaceutical (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
TABLE 24: Biopharmaceutical (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Sterile (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
TABLE 26: Sterile (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
TABLE 27: Sterile (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
TABLE 28: Non-Sterile (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 29: Non-Sterile (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
TABLE 30: Non-Sterile (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Pharmaceutical Contract Manufacturing Market Share (in %) by Company: 2018 & 2025

Market Analytics
TABLE 31: United States Pharmaceutical Contract Manufacturing Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 32: Pharmaceutical Contract Manufacturing Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 33: United States Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
TABLE 34: United States Pharmaceutical Contract Manufacturing Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
TABLE 35: Pharmaceutical Contract Manufacturing Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
TABLE 36: Pharmaceutical Contract Manufacturing Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
TABLE 37: United States Pharmaceutical Contract Manufacturing Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 38: Pharmaceutical Contract Manufacturing Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
TABLE 39: Pharmaceutical Contract Manufacturing Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027

CANADA

TABLE 40: Canadian Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 41: Canadian Pharmaceutical Contract Manufacturing Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 42: Pharmaceutical Contract Manufacturing Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
TABLE 43: Canadian Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 44: Pharmaceutical Contract Manufacturing Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 45: Canadian Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
TABLE 46: Canadian Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 47: Pharmaceutical Contract Manufacturing Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 48: Canadian Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

JAPAN

TABLE 49: Japanese Market for Pharmaceutical Contract Manufacturing: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 50: Pharmaceutical Contract Manufacturing Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 51: Japanese Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
TABLE 52: Japanese Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
TABLE 53: Japanese Pharmaceutical Contract Manufacturing Market in US$ Million by Application: 2012-2019
TABLE 54: Pharmaceutical Contract Manufacturing Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
TABLE 55: Japanese Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
TABLE 56: Japanese Pharmaceutical Contract Manufacturing Market in US$ Million by End-Use: 2012-2019
TABLE 57: Pharmaceutical Contract Manufacturing Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027

CHINA

TABLE 58: Chinese Pharmaceutical Contract Manufacturing Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 59: Pharmaceutical Contract Manufacturing Historic Market Analysis in China in US$ Million by Product Type: 2012-2019
TABLE 60: Chinese Pharmaceutical Contract Manufacturing Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 61: Chinese Demand for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
TABLE 62: Pharmaceutical Contract Manufacturing Market Review in China in US$ Million by Application: 2012-2019
TABLE 63: Chinese Pharmaceutical Contract Manufacturing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
TABLE 64: Chinese Demand for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
TABLE 65: Pharmaceutical Contract Manufacturing Market Review in China in US$ Million by End-Use: 2012-2019
TABLE 66: Chinese Pharmaceutical Contract Manufacturing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027

EUROPE

Market Facts & Figures

European Pharmaceutical Contract Manufacturing Market: Competitor Market Share Scenario (in %) for 2018 & 2025

Market Analytics
TABLE 67: European Pharmaceutical Contract Manufacturing Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 68: Pharmaceutical Contract Manufacturing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 69: European Pharmaceutical Contract Manufacturing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 70: European Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 71: Pharmaceutical Contract Manufacturing Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 72: European Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
TABLE 73: European Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 74: Pharmaceutical Contract Manufacturing Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 75: European Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
TABLE 76: European Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 77: Pharmaceutical Contract Manufacturing Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 78: European Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

FRANCE

TABLE 79: Pharmaceutical Contract Manufacturing Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 80: French Pharmaceutical Contract Manufacturing Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 81: French Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
TABLE 82: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
TABLE 83: French Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by Application: 2012-2019
TABLE 84: French Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
TABLE 85: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
TABLE 86: French Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 87: French Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027

GERMANY

TABLE 88: Pharmaceutical Contract Manufacturing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 89: German Pharmaceutical Contract Manufacturing Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 90: German Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
TABLE 91: Pharmaceutical Contract Manufacturing Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
TABLE 92: German Pharmaceutical Contract Manufacturing Market in Retrospect in US$ Million by Application: 2012-2019
TABLE 93: Pharmaceutical Contract Manufacturing Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
TABLE 94: Pharmaceutical Contract Manufacturing Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 95: German Pharmaceutical Contract Manufacturing Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 96: Pharmaceutical Contract Manufacturing Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027

ITALY

TABLE 97: Italian Pharmaceutical Contract Manufacturing Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 98: Pharmaceutical Contract Manufacturing Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019
TABLE 99: Italian Pharmaceutical Contract Manufacturing Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 100: Italian Demand for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
TABLE 101: Pharmaceutical Contract Manufacturing Market Review in Italy in US$ Million by Application: 2012-2019
TABLE 102: Italian Pharmaceutical Contract Manufacturing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
TABLE 103: Italian Demand for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
TABLE 104: Pharmaceutical Contract Manufacturing Market Review in Italy in US$ Million by End-Use: 2012-2019
TABLE 105: Italian Pharmaceutical Contract Manufacturing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM

TABLE 106: United Kingdom Market for Pharmaceutical Contract Manufacturing: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 107: Pharmaceutical Contract Manufacturing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 108: United Kingdom Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
TABLE 109: United Kingdom Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by Application: 2020 to 2027
TABLE 110: United Kingdom Pharmaceutical Contract Manufacturing Market in US$ Million by Application: 2012-2019
TABLE 111: Pharmaceutical Contract Manufacturing Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
TABLE 112: United Kingdom Demand Estimates and Forecasts for Pharmaceutical Contract Manufacturing in US$ Million by End-Use: 2020 to 2027
TABLE 113: United Kingdom Pharmaceutical Contract Manufacturing Market in US$ Million by End-Use: 2012-2019
TABLE 114: Pharmaceutical Contract Manufacturing Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE

TABLE 115: Rest of Europe Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 116: Pharmaceutical Contract Manufacturing Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 117: Rest of Europe Pharmaceutical Contract Manufacturing Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
TABLE 118: Rest of Europe Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 119: Pharmaceutical Contract Manufacturing Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 120: Rest of Europe Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
TABLE 121: Rest of Europe Pharmaceutical Contract Manufacturing Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 122: Pharmaceutical Contract Manufacturing Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 123: Rest of Europe Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC

TABLE 124: Pharmaceutical Contract Manufacturing Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 125: Asia-Pacific Pharmaceutical Contract Manufacturing Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 126: Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
TABLE 127: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
TABLE 128: Asia-Pacific Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by Application: 2012-2019
TABLE 129: Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
TABLE 130: Pharmaceutical Contract Manufacturing Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
TABLE 131: Asia-Pacific Pharmaceutical Contract Manufacturing Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 132: Asia-Pacific Pharmaceutical Contract Manufacturing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027

REST OF WORLD

TABLE 133: Rest of World Pharmaceutical Contract Manufacturing Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 134: Rest of World Pharmaceutical Contract Manufacturing Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 135: Pharmaceutical Contract Manufacturing Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
TABLE 136: Rest of World Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 137: Pharmaceutical Contract Manufacturing Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 138: Rest of World Pharmaceutical Contract Manufacturing Market Share Analysis by Application: 2012 VS 2020 VS 2027
TABLE 139: Rest of World Pharmaceutical Contract Manufacturing Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 140: Pharmaceutical Contract Manufacturing Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 141: Rest of World Pharmaceutical Contract Manufacturing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

Total Companies Profiled: 112

Note: Product cover images may vary from those shown
Adroll
adroll